Cracking the Pathogenic Code
AgnoSci is a California-based biotechnology company developing a novel in-vitro diagnostic platform to detect infectious disease pathogens. Our proprietary diagnostic test kit is pathogen-agnostic and uses a Biomimetic Sensor Array with Differential Affinity approach to detect infection through the host's immune response patterns. Our test kits are designed to run on pre-existing hospital hardware with no capital equipment investment required from clinical partners.
What is Agnostic Pathogen Detection?
01 — Broad Spectrum Detection
Agnostic pathogen detection is a highly versatile method that identifies a wide variety of pathogens, including various bacteria, viruses, fungi, and parasites, without specifically targeting any certain species or strains. This approach allows for a comprehensive analysis of potential infectious agents, making it a valuable tool in clinical and environmental settings.
02 — Unbiased Approach
Methods do not rely on any prior assumptions regarding the identity of the pathogen, which allows for the efficient detection of both known and novel pathogens. This flexibility is crucial for accurately identifying a wide range of infectious agents that may be present in various samples.
03 — Machine Learning
Using a modified decision tree in multiomics research effectively identifies distinct biomarkers linked to different pathogenic classes, enhancing analysis of complex biological data for better correlations between biomarkers and related diseases.
04 — In Vitro Diagnostic
Identified biomarkers are used to design our in-vitro diagnostic, the Molecular Pathogen Kit, which can be used in basic clinical labs, resulting in rapid turnaround of results, and detection of pathogens.
